# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-18-020312
Filing Date
2018-04-12
Accepted
2018-04-12 16:55:18
Documents
5
Effectiveness Date
2018-04-12

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | tv490938_defa14a.htm | DEFA14A | 20334
2 | GRAPHIC | image_001.jpg | GRAPHIC | 289008
3 | GRAPHIC | image_002.jpg | GRAPHIC | 380471
4 | GRAPHIC | image_003.jpg | GRAPHIC | 144642
5 | GRAPHIC | image_004.jpg | GRAPHIC | 4150
| Complete submission text file | 0001144204-18-020312.txt |  | 1148973

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50626 | Film No.: 18752570
SIC: 2834 Pharmaceutical Preparations